ANKUR TYAGI
Mumbai/Pune, September 23, 2025 – In a major step towards preventive, digital-first healthcare, Vidal Health, a wholly owned subsidiary of Bajaj Finserv Health, has partnered with the Serum Institute of India (SII) to make the HPV vaccine more accessible across India.
Starting October 1, 2025, the Vidal Health digital platform will provide the country’s first end-to-end, cashless HPV vaccination programme. The initiative offers a seamless journey—from booking doctor appointments and giving digital consent to receiving vaccination certificates—without any paperwork. The programme also includes dosage reminders, adherence tracking, and network management to ensure continuity of care.
Why This Collaboration Matters
- Cervical cancer prevention: HPV vaccination is a proven tool, but access and awareness remain key challenges in India.
- Digital convenience: Users can register online, pay cashless, and track their multi-dose vaccination schedule.
- Corporate reach: Employees can get vaccinated at offices or partner clinics, ensuring large-scale adoption.
- Cost efficiency: By reducing hospitalisations and out-of-pocket expenses, the initiative helps optimise healthcare spending.
Leaders Speak
Sanjiv Bajaj, Chairman & MD, Bajaj Finserv:
“India’s healthcare is shifting from reactive to preventive care. This collaboration with Serum Institute strengthens our vaccination programme and empowers people to manage health digitally, cutting long-term costs while improving well-being.”
Adar Poonawalla, CEO, Serum Institute of India:
“HPV vaccination can significantly reduce cervical cancer risk, but wider access is critical. By using Vidal Health’s platform, we can deliver vaccines efficiently at scale, strengthening public health outcomes.”
Neetha Uthaiah, Whole Time Director, Vidal Health:
“This partnership helps us deliver transparent, preventive healthcare while expanding beyond claims processing and wellness programmes. It is designed to make vaccination affordable, inclusive, and easy to adopt.”
Building a Connected Health Ecosystem
This collaboration brings together healthcare providers, vaccine manufacturers, and national digital platforms like Aarogya Setu, reinforcing India’s preventive healthcare infrastructure.
Vidal Health already offers doctor consultations, diagnostics, health check-ups, wellness programmes, and health financing on its platform. With HPV vaccination added to its preventive care portfolio, the company is positioning itself as a holistic health partner for individuals and corporates.
Bottom Line
By combining Serum Institute’s vaccine leadership with Vidal Health’s digital-first platform, this collaboration aims to increase HPV vaccine adoption, reduce cervical cancer risk, and cut healthcare costs, marking a milestone in India’s preventive healthcare journey.
Abhishek Sinha
